ERBB2 TARGETED ANTITUMOR STRATEGIES IN BREAST CANCER

$235,091R01FY2000CANIH

Vanderbilt University, Nashville TN

Investigators

Carlos L Arteaga

Linked publications, trials & patents

Paper 29420467 Paper 28396358 Paper 28381415 Paper 28274957 Paper 26637440 Paper 26508629 Paper 26000030 Paper 25500087 Paper 25034624 Paper 25032256 Paper 24651011 Paper 24451154 Paper 24272818 Paper 24130112 Paper 23999432 Paper 23948973 Paper 23940356 Paper 23928993 Paper 23918797 Paper 23905624 Paper 23794708 Paper 23650407 Paper 23633485 Paper 23224399 Paper 23204226 Paper 22552284 Paper 22471661 Paper 22461506 Paper 22178756 Paper 22145099 Paper 22124364 Paper 22114931 Paper 22049316 Paper 21908557 Paper 21670086 Paper 21499296 Paper 21482676 Paper 21457523 Paper 21385943 Paper 21368164 Paper 21324925 Paper 21307659 Paper 21248299 Paper 20593313 Paper 20581867 Paper 20530877 Paper 20383197 Paper 20179241 Paper 19934303 Paper 19584166 Paper 19458057 Paper 19435893 Paper 19147560 Paper 19128439 Paper 19106609 Paper 18829509 Paper 18822378 Paper 18625725 Paper 18579663 Paper 18568074 Paper 18386930 Paper 18180460 Paper 17927978 Paper 17699871 Paper 17407594 Paper 17317812 Paper 17204482 Paper 17085387 Paper 17082181 Paper 17018616 Paper 16849543 Paper 16849436 Paper 16847283 Paper 16843263 Paper 16766261 Paper 16493009 Paper 16489017 Paper 16467117 Paper 16377175 Paper 16186809 Paper 15805282 Paper 15604278 Paper 15193255 Paper 15052538 Paper 14998487 Paper 14734493 Paper 14645415 Paper 14508084 Paper 12864943 Paper 12743604 Paper 12738709 Paper 12648471 Paper 12631388 Paper 12538508 Paper 12422308 Trial NCT00633750 Patent 9745377 Patent 9023362 Patent 8501417 Patent 8486413

View original record on NIH RePORTER →

ERBB2 TARGETED ANTITUMOR STRATEGIES IN BREAST CANCER · GrantIndex